These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31625373)

  • 1. Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Yu F; Wang X; Zhao H; Hao Y; Wang W
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
    Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
    Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-29a and miR-122 as Potential Biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD).
    Jampoka K; Muangpaisarn P; Khongnomnan K; Treeprasertsuk S; Tangkijvanich P; Payungporn S
    Microrna; 2018; 7(3):215-222. PubMed ID: 29848284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
    Xu Q; Li Y; Shang YF; Wang HL; Yao MX
    World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population.
    He Z; Yang JJ; Zhang R; Li HT; Wu L; Jiang F; Jia WP; Hu C
    J Dig Dis; 2019 Apr; 20(4):189-195. PubMed ID: 30756471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity.
    Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP
    Cell Physiol Biochem; 2016; 39(6):2239-2248. PubMed ID: 27832630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA-486-5p expression in obese Egyptian children and its possible association with fatty liver.
    Al Azzouny MA; Behiry EG; Behairy OG; Abd Ellraouf HA; Elfallah AA
    Diabetes Metab Syndr; 2021; 15(5):102258. PubMed ID: 34509791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Matono T; Kato J; Tokunaga S; Sugihara T; Hiramatsu A; Hyogo H; Tobita H; Sato S; Kawanaka M; Hara Y; Hino K; Chayama K; Murawaki Y; Isomoto H
    PLoS One; 2020; 15(2):e0219412. PubMed ID: 32106257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.
    Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
    Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
    Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
    Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
    Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
    Pillai SS; Lakhani HV; Zehra M; Wang J; Dilip A; Puri N; O'Hanlon K; Sodhi K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    PLoS One; 2014; 9(8):e105192. PubMed ID: 25141008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Value and Role of miR-129-5p in Non-Alcoholic Fatty Liver Disease.
    Wang Y; Feng Y; Zhang H; Niu Q; Liang K; Bian C; Li H
    Horm Metab Res; 2021 Oct; 53(10):692-698. PubMed ID: 34528223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.
    Lei L; Zhou C; Yang X; Li L
    Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):819-831. PubMed ID: 29569260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.
    Ye D; Zhang T; Lou G; Xu W; Dong F; Chen G; Liu Y
    Life Sci; 2018 Sep; 208():201-207. PubMed ID: 30030064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients.
    Ng L; Sin RW; Cheung DH; Leung WK; Man AT; Lo OS; Law WL; Foo DC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children.
    Brandt S; Roos J; Inzaghi E; Kotnik P; Kovac J; Battelino T; Cianfarani S; Nobili V; Colajacomo M; Kratzer W; Denzer C; Fischer-Posovszky P; Wabitsch M
    Pediatr Obes; 2018 Mar; 13(3):175-182. PubMed ID: 29271122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.
    Ando Y; Yamazaki M; Yamada H; Munetsuna E; Fujii R; Mizuno G; Ichino N; Osakabe K; Sugimoto K; Ishikawa H; Ohashi K; Teradaira R; Ohta Y; Hamajima N; Hashimoto S; Suzuki K
    Sci Rep; 2019 Dec; 9(1):18856. PubMed ID: 31827150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.